» Authors » Aslam Ejaz

Aslam Ejaz

Explore the profile of Aslam Ejaz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 292
Citations 3183
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamad A, Zhang H, Zhang Y, Shen C, Fa P, Huang H, et al.
BMC Sports Sci Med Rehabil . 2025 Mar; 17(1):50. PMID: 40087747
Background: There is a gap in knowledge regarding the utility of preoperative exercise (PEx) among gastrointestinal (GI) cancer patients undergoing surgery and how PEx impacts surgical outcomes. This study seeks...
2.
Walsh A, Guo M, Leuschner T, Ejaz A, Pawlik T, Wells-Di Gregorio S, et al.
Ann Surg Oncol . 2025 Feb; PMID: 40000563
Background: Unlike advanced cancer populations, for whom early and routine specialty palliative care (PC) referral has demonstrated clear benefits for quality of life and symptom control, evidence supporting PC for...
3.
Underwood P, Leuschner T, Ejaz A, Dillhoff M, Tsai S, Pawlik T, et al.
J Am Coll Surg . 2025 Jan; PMID: 39803957
Background: Neoadjuvant therapy (NT) is increasingly utilized for patients with pancreatic ductal adenocarcinoma (PDAC). Disease progression, toxicity, and failure to undergo surgical resection are common during NT, yet little research...
4.
Moazzam Z, Hawkins A, Regenbogen S, Holder-Murray J, Silviera M, Ejaz A, et al.
Surgery . 2025 Jan; 180():109062. PMID: 39793415
Background: Surgical resection is the cornerstone of rectal cancer treatment but can be associated with adverse short-term postoperative outcomes. We sought to assess the factors associated with achievement of optimal...
5.
Quinn P, Tounkara F, Grau Rodriguez M, Chahal K, Saiyed S, Gutta G, et al.
Clin Res Hepatol Gastroenterol . 2024 Dec; 49(2):102519. PMID: 39722361
Purpose: Despite the disproportionate impact of hepatocellular carcinoma (HCC) on Hispanic patients, reported outcomes are limited, particularly among subpopulations. Our study aimed to evaluate outcomes in access to care and...
6.
Cloyd J, Khatri R, Sarna A, Stevens L, Heh V, Dillhoff M, et al.
Ann Surg Open . 2024 Dec; 5(4):e520. PMID: 39711683
Background: Although resection is generally necessary for curative-intent treatment of most solid organ cancers, surgery is occasionally aborted due to intraoperative findings. Following aborted cancer surgery, patients have unique care...
7.
Shannon A, Palettas M, Sarna A, Huang E, Kneuertz P, Dillhoff M, et al.
J Gastrointest Cancer . 2024 Dec; 56(1):31. PMID: 39661262
Purpose: Neoadjuvant therapy (NT) is increasingly used for gastrointestinal (GI) and hepatopancreatobiliary (HPB) cancers. Risk factors for surgical attrition during NT are poorly understood. A planned secondary analysis of patient-reported...
8.
Quinn P, Tounkara F, Chahal K, Grau Rodriguez M, Kim A, Ejaz A
J Surg Res . 2024 Nov; 304:335-347. PMID: 39608314
Introduction: In aggregate, Asian patients have a higher incidence and mortality from gastric cancer (GC) than Non-Hispanic White (NHW) patients. However, there is a lack of data regarding outcomes among...
9.
Bauer P, Gamboa A, Otegbeye E, Chapman Jr W, Rivard S, Regenbogen S, et al.
J Surg Oncol . 2024 Oct; PMID: 39400312
Background And Objectives: The RAPIDO trial showed promising rates of pathologic complete response (pCR) after neoadjuvant short-course radiation with consolidation chemotherapy (total neoadjuvant therapy [SC TNT]) for rectal cancer. Only...
10.
Althans A, Holder-Murray J, Hopkins K, Gamboa A, Regenbogen S, Silviera M, et al.
J Surg Res . 2024 Oct; 303:254-260. PMID: 39383599
Introduction: Patients with resected locally advanced rectal cancer (LARC) and an incomplete total mesorectal excision (TME) have worse oncologic outcomes. The associations between TME grade, adjuvant therapy receipt, and oncologic...